تولید مواد اولیه داروئی البرز بالک (سهامی خاص)
دبالک | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 17,140 0.12
Close Price: 16,900
Financial Ratios
AGM
Interim
2026/05/19 Fiscal Year 2025/12/2112 Month | 2025/05/25 Fiscal Year 2024/12/2012 Month | 2024/05/05 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 13.72 | 3.2 | 13.71 | |
Gross Profit to Sales | 16.69 | 3.22 | 17.09 | |
Operating Margin | 24.71 | 19.6 | 28.07 | |
Gross Profit to Sales | 32.35 | 27.12 | 34.12 | |
Net Profit to Gross Profit | 42.42 | 11.8 | 40.18 | |
Return on Assets (ROA) | 13.41 | 2.74 | 12.01 | |
Return on Capital (%) | 82.45 | 12.36 | 100.8 | |
Return on Equity (ROE) | 37.96 | 16.51 | 49.99 | |
Working Capital Return | 28.16 | 13.74 | 68.18 | |
Fixed Asset Return | 179.5 | 39.58 | 180.43 | |
Loan Benefit Assessment | 2.83 | 6.02 | 4.16 | |
Current Ratio | 2.06 | 1.27 | 1.23 | |
Quick Ratio | 1.74 | 0.68 | 0.58 | |
Liquidity Ratio | 0.17 | 0.02 | 0.01 | |
Net Working Capital | 5,328,003 | 1,636,799 | 1,360,302 | |
Current Assets Ratio | 0.92 | 0.93 | 0.93 | |
Inventory Turnover | 128.22 | 263.19 | 242.19 | |
Receivables Collection Period | 228.21 | 180.32 | 129.88 | |
Inventory to Working Capital | 0.31 | 2.17 | 2.82 | |
Working Capital Turnover | 2.05 | 4.29 | 4.97 | |
Fixed Asset Turnover | 13.08 | 12.37 | 13.16 | |
Total Asset Turnover | 0.98 | 0.86 | 0.88 | |
Debt Ratio | 0.65 | 0.83 | 0.76 | |
Debt to Equity | 1.83 | 5.02 | 3.16 | |
Long-Term Debt to Equity | 0.56 | 0.63 | 0.02 | |
Current Debt to Equity | 1.27 | 4.39 | 3.14 | |
Equity Ratio | 35.31 | 16.6 | 24.02 | |
Debt Coverage Ratio | 0.37 | 0.66 | 14.57 |
